These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16461829)

  • 1. Prevention of coronary heart disease and the National Cholesterol Education Program.
    Kuller LH
    Circulation; 2006 Feb; 113(5):598-600. PubMed ID: 16461829
    [No Abstract]   [Full Text] [Related]  

  • 2. New guidelines from the National Cholesterol Education Program: what is the impact on risk assessment?
    Lowden JA
    J Insur Med; 2002; 34(1):26-30. PubMed ID: 15303591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying the new cholesterol guidelines to your practice.
    Geisler SL
    JAAPA; 2001 Nov; 14(11):12-4, 17-8, 21-3. PubMed ID: 11766422
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship of subclinical coronary atherosclerosis and National Cholesterol Education Panel guidelines in asymptomatic Brazilian men.
    Nasir K; Santos RD; Roguin A; Carvalho JA; Meneghello R; Blumenthal RS
    Int J Cardiol; 2006 Mar; 108(1):68-75. PubMed ID: 16516700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two approaches of coronary risk assessment--do they work?
    Ajani UA; Ford ES
    Am J Cardiol; 2006 Mar; 97(6):765-7. PubMed ID: 16516571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Millions of healthy people can be considered ill because of the American cholesterol policy].
    Ravnskov U
    Lakartidningen; 2001 Oct; 98(42):4574-7. PubMed ID: 11715230
    [No Abstract]   [Full Text] [Related]  

  • 7. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
    Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
    Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin therapy now recommended for people at risk for heart disease.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Feb; 13(3):1-2, 5. PubMed ID: 12428631
    [No Abstract]   [Full Text] [Related]  

  • 9. Reducing cardiovascular risk: trends in risk, risk assessment, and cholesterol management.
    Davidson MH
    Postgrad Med; 2004 Sep; 116(3 Suppl):7-12. PubMed ID: 19667670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trial.
    de Lemos JA; Wiviott SD; Murphy SA; Blazing MA; Lewis EF; Califf RM; Pfeffer MA; Braunwald E
    Am J Cardiol; 2006 Sep; 98(6):739-42. PubMed ID: 16950174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age and time need not and should not be eliminated from the coronary risk prediction models.
    Vasan RS; D'Agostino RB
    Circulation; 2005 Feb; 111(5):542-5. PubMed ID: 15699273
    [No Abstract]   [Full Text] [Related]  

  • 12. Doctors at the heart of this cardiac DM program's success.
    Healthc Demand Dis Manag; 1999 Jun; 5(6):90-1. PubMed ID: 10538687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus development summaries. Lowering blood cholesterol to prevent heart disease. National Institutes of Health.
    Conn Med; 1985 Jun; 49(6):357-64. PubMed ID: 4017584
    [No Abstract]   [Full Text] [Related]  

  • 14. Using nontraditional risk factors in coronary heart disease risk assessment.
    Lin KW; Garcia SM
    Am Fam Physician; 2011 Feb; 83(4):449. PubMed ID: 21322521
    [No Abstract]   [Full Text] [Related]  

  • 15. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of C-reactive protein as a predictor of vascular risk.
    Katrinchak C; Fritz K
    J Am Acad Nurse Pract; 2007 Jul; 19(7):335-40. PubMed ID: 17680898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol and coronary events. The current thinking.
    Jones PH
    Postgrad Med; 2003 Apr; 113(4 Suppl):5-14. PubMed ID: 19667618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult treatment panel III and the management of dyslipidemia risk factors.
    Stein EA
    Postgrad Med; 2002 Oct; 112(4 Suppl):12-7. PubMed ID: 19667595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Cholesterol Education Program. Scientific rationale.
    LaRosa JC
    J Reprod Med; 1989 Sep; 34(9 Suppl):675-90. PubMed ID: 2681752
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors of Hong Kong Chinese patients with coronary heart disease.
    Chair SY; Lee SF; Lopez V; Ling EM
    J Clin Nurs; 2007 Jul; 16(7):1278-84. PubMed ID: 17584346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.